KIF4A and neoplasm: Gene Silencing Therapy: Silencing KIF4A expression through siRNA, shRNA, or CRISPR-Cas9 technology (in vitro and in vivo mouse xenograft models) has been demonstrated to effectively inhibit tumour growth, reverse chemotherapy resistance, and enhance the immune microenvironment [4, 5, 9, 51, 90, 93].